Hjem › Leverkreft (hepatocellulært karcinom) › Minnesota › Rochester
Kliniske studier for Leverkreft (hepatocellulært karcinom) i Rochester, MN
12 studier for Leverkreft (hepatocellulært karcinom) søker deltakere på steder i og rundt Rochester (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
RekruttererFase 1/2
- Mayo Clinic in Rochester, Rochester
A Phase 1 Study of the Safety and Tolerability of CTX-10726
RekruttererFase 1
- Mayo Clinic Rochester, Rochester
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekruttererFase 1
- Exelixis Clinical Site #68, Rochester
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
RekruttererFase 1/2
- Research Facility, Rochester
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
RekruttererFase 3
- Research Site, Rochester
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Mayo Clinic, Rochester
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
RekruttererFase 2
- Mayo Clinic in Rochester, Rochester
DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
RekruttererObservasjonsstudie
- Mayo Clinic, Rochester
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
RekruttererFase 1
- Clinical Trial Site, Rochester
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
RekruttererObservasjonsstudie
- Mayo Clinic in Rochester, Rochester
The Dragon PLC Trial (DRAGON-PLC)
Rekrutterer
- Mayo Clinic, Rochester
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
RekruttererFase 1/2
- Mayo Clinic in Minnesota, Rochester
Leverkreft (hepatocellulært karcinom)-studier i andre byer
- Houston, TX31 studier
- New York City, NY24 studier
- Dallas, TX19 studier
- Los Angeles, CA19 studier
- Boston, MA18 studier
- Cleveland, OH18 studier
- Chicago, IL16 studier
- Philadelphia, PA16 studier
- Pittsburgh, PA15 studier
- San Francisco, CA14 studier
- Orange, CA14 studier
- Jacksonville, FL14 studier
Andre studier i Rochester
- Brystkreft42 studier
- Ikke-småcellet lungekreft37 studier
- Metastatisk kreft31 studier
- Kreft (alle typer)30 studier
- Eggstokkreft29 studier
- Kolorektal kreft29 studier
- Multipelt myelom24 studier
- Hjertesvikt22 studier
- Prostatakreft22 studier
- Pankreaskreft22 studier
- Endometriekreft20 studier
- Lungekreft20 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.